Generics' High Court Win Opens New Battleground With Pharmas
The U.S. Supreme Court's decision Tuesday allowing Caraco Pharmaceutical Laboratories Ltd. to challenge as overbroad Novo Nordisk A/S's use code for a patent covering diabetes drug Prandin opens the door to...To view the full article, register now.
Already a subscriber? Click here to view full article